PBM Drug Monograph Template

Non-Hodgkin’s lymphoma. At 1.38mg/m2. 1 CR, 2 PR, 3SD, 1MR, 1PD(?) 2PR (1 Mantle cell, 1 follicular). Adverse Events: Thrombocytopenia 74% (most common gr 3 event) Anemia 48%. Leukopenia 48%. Fatigue 59%. Nausea 52%. Vomiting 30%. Neuropathy in 5, related to PS341 in 3. Late toxicities: Rash, hyperbilirubinemia, AST/ALT elevation Aghajanian ... ................
................